China Castson 81 Finance Company Limited (stock code: 810) announced that all resolutions regarding a proposed Rights Issue, the Underwriting Agreement, and the associated Whitewash Waiver were approved at its Special General Meeting on 2 March 2026. The ordinary resolution was passed by independent shareholders with 27.69 million votes in favor and no votes against. The special resolution, which pertains to the Whitewash Waiver and related transactions, was also passed with 27.69 million votes in favor and none against.
The company highlighted that 203.64 million shares were in issue as of the meeting date, with no treasury or repurchased shares pending cancellation. Dr. Lam and Goodchamp Investments, which hold 17.34% of the issued shares, were among those required to abstain from voting on certain resolutions. Consequently, 168.34 million shares were eligible to vote at the meeting.
Upon full acceptance of the Rights Issue by all qualifying shareholders, total issued shares would increase to 712.75 million. If only Dr. Lam and Goodchamp subscribe to the Rights Issue and place all unsubscribed shares, their stake may reach approximately 74.98% of the company’s enlarged issued share capital.
The Whitewash Waiver was granted by the Executive on 25 February 2026, subject to approval thresholds and restrictions on share disposals and acquisitions. The Rights Issue is expected to follow the timetable set out in the circular, with the last cum-rights trading day on 3 March 2026 and the first ex-rights trading day on 4 March 2026. The company cautioned that the Rights Issue remains conditional on the Underwriting Agreement becoming unconditional and advised shareholders and investors to exercise caution when dealing in the shares and nil-paid rights. The Directors accept full responsibility for the accuracy of the disclosed information and confirm that there are no other facts that would make any statement misleading.
Comments